Posts

Showing posts with the label enhertu patient assistance

ENHERTU vs. Traditional Chemotherapy: A Comparison of Efficacy and Side Effects

Image
Cancer is a devastating disease that affects millions of people worldwide. However, advancements in cancer treatment have brought about new hope for patients. One such advancement is ENHERTU , a cancer medication that has shown remarkable results in the treatment and management of various types of cancer. In this blog, we will explore ENHERTU's journey in cancer treatment and management, including its mechanism of action, designations, approvals, cost, and patient assistance. What is ENHERTU and How is it Used? ENHERTU is a type of cancer medication that is designed to treat HER2-positive breast cancer , gastric cancer , and non-small cell lung cancer . It is a type of antibody-drug conjugate that targets the HER2 protein on cancer cells, delivering a potent chemotherapy drug directly to the cancer cells while minimizing damage to healthy cells. ENHERTU is administered through intravenous infusion once every three weeks, and the dosage is dependent on the patient's body weight